Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.3660
-0.0325 (-8.16%)
At close: Oct 27, 2026, 4:00 PM EDT
0.3651
-0.0009 (-0.25%)
After-hours: Oct 27, 2026, 4:16 PM EDT
Oragenics Market Cap
Oragenics has a market cap or net worth of $1.65 million as of October 27, 2026. It is the 48,282nd most valuable company in the world and the 6,480th biggest in the United States. Its market cap has decreased by 69.42% in one year.
Market Cap
1.65M
Enterprise Value
-2.21M
1-Year Change
-69.42%
Global Rank
Country Rank
#6,480 United States
Category
ChartMarket Cap Chart
Since February 27, 2004, Oragenics's market cap has increased from $1.60M to $1.65M, an increase of 3.21%. That is a compound annual growth rate of 0.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 1.65M | -49.96% |
| Dec 31, 2025 | 3.30M | -26.67% |
| Dec 31, 2024 | 4.50M | -68.97% |
| Dec 29, 2023 | 14.50M | 17.89% |
| Dec 30, 2022 | 12.30M | -76.30% |
| Dec 31, 2021 | 51.90M | 89.42% |
| Dec 31, 2020 | 27.40M | 13.69% |
| Dec 31, 2019 | 24.10M | -4.74% |
| Dec 31, 2018 | 25.30M | 118.10% |
| Dec 29, 2017 | 11.60M | -56.23% |
| Dec 30, 2016 | 26.50M | -51.55% |
| Dec 31, 2015 | 54.70M | 69.88% |
| Dec 31, 2014 | 32.20M | -62.43% |
| Dec 31, 2013 | 85.70M | 18.53% |
| Dec 31, 2012 | 72.30M | 1,125.42% |
| Dec 30, 2011 | 5.90M | -65.29% |
| Dec 31, 2010 | 17.00M | -37.50% |
| Dec 31, 2009 | 27.20M | 186.32% |
| Dec 31, 2008 | 9.50M | -17.39% |
| Dec 31, 2007 | 11.50M | -50.00% |
| Dec 29, 2006 | 23.00M | 253.85% |
| Dec 30, 2005 | 6.50M | -88.25% |
| Dec 31, 2004 | 55.30M | 3,356.25% |
| Feb 27, 2004 | 1.60M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PMGC Holdings | 2.16M |
| Revelation Biosciences | 2.11M |
| BioRestorative Therapies | 1.94M |
| Kairos Pharma | 1.91M |
| GeoVax Labs | 1.83M |
| Silo Pharma | 1.83M |
| XORTX Therapeutics | 1.67M |
| Onconetix | 1.65M |